1-877-804-4900

banner-highlights-rx-summit

Clinical Home Page Slider 2014

Clinical oversight for injured workers to prevent abuse

bannernew

websitebanner1

Ancillary Benefits Management for Workers’ Compensation

websitebanner2

Mobile app for workers compensation

About Us

myMatrixx provides pharmacy and ancillary services for workers’ compensation programs. Our services control costs with proactive clinical oversight throughout the claims process. With one online tool also available in a mobile app, clients can manage claims with real time data and detailed reporting.

Learn more

The Latest

News

myMatrixx Chief Clinical Officer Phil Walls Honored as CompPharma’s 2015 Person of the Year

Posted by On December 22, 2015

TAMPA, FL, December 18, 2015 – Phil Walls, Chief Clinical Officer for myMatrixx, has been recognized as CompPharma’s Person of the Year for 2015. CompPharma is a consortium of workers’ compensation pharmacy benefit management (PBM) companies that provides a platform for developing cost-effective tools and services that benefit its PBM members.  myMatrixx, a Tampa-based pharmacy […]

myMatrixx President Artemis Emslie Named to 2015 “Women to Watch” List

Posted by On December 21, 2015

One of 25 Women Honored as Leaders in the Insurance Industry TAMPA, December 8, 2015 – myMatrixx, a Tampa-based pharmacy and ancillary medical benefit management company, announced that Artemis Emslie, President of myMatrixx, has been recognized by Business Insurance magazine as an honoree on their 2015 “Women to Watch” list. The annual list spotlights 25 […]

Blog

Buyer Beware!

Posted by On May 26, 2016

By Michael Nguyen, PharmD and Phil Walls, RPh PatchWerx Alert If you haven’t heard of PatchWerx yet, please be on the alert for the following products from this manufacturer: In this age of life-saving specialty drugs that cost upwards of $1000 a day, one might think that PatchWerx Labs falls into this category of specialty […]

Drug of the Month – Vivlodex™ (meloxicam)

Posted by On April 12, 2016

By: Krupa Patel, PharmD candidate 2016 and Alan Rook, PharmD What is Vivlodex? Vivlodex (meloxicam) is a single-source brand medication that was FDA approved in October 2015 for the management of osteoarthritis (OA) pain. Vivlodex is a nonsteroidal anti-inflammatory drug (NSAID) that prevents the synthesis of prostaglandins in body tissue by inhibiting COX-1 and COX-2. […]

Visit Blog

Videos

View All